LONDON — Neglected tropical diseases (NTDs) won fresh UK political backing on Feb. 4 as ministers, MPs, researchers and advocates gathered at the Houses of Parliament and unveiled £3 million in new operational research funding. The package, presented as part of a wider push to fold NTD diagnosis, treatment and care into frontline health systems, signaled an attempt to restore momentum in a field campaigners say has been squeezed by uneven global financing, Feb. 4, 2026.
At the “Leaving No One Behind: Reaching 1 billion people affected by NTDs” Parliament event, co-hosted by the UK Coalition Against NTDs and the All-Party Parliamentary Group on Malaria and NTDs, Baroness Chapman of Darlington said the new money would support operational research on female genital schistosomiasis, migrant health and stronger service delivery. She told attendees that lasting progress has to be “African-owned, African-led, and African delivered,” tying the funding to country-led implementation rather than a purely donor-driven model.
The government later put the commitment on a formal footing in a Feb. 17 written parliamentary answer, which said the UK continues to invest in NTD research, including £3 million for the Coalition for Operational Research on NTDs for research on female genital schistosomiasis. The same answer also pointed to up to £15 million for the Eliminating Lymphatic Filariasis in Africa program, suggesting ministers want the Parliament announcement to land as part of a broader, if still selective, re-engagement.
Why neglected tropical diseases still matter
WHO’s latest neglected tropical diseases data show both real gains and a stubbornly large remaining burden: 61 countries had eliminated at least one NTD as of March 5, 2026, and the number of people requiring interventions had fallen 36% since 2010. That is significant progress, but it also means millions of people still live with diseases that thrive where health care, safe water, sanitation and political attention run thin.
The integration message got another lift the same day in Geneva, where WHO released a new essential care package linking NTD services with mental health and stigma reduction. The guidance argues that elimination efforts will fall short if countries treat depression, anxiety, discrimination and social exclusion as side issues rather than part of routine care.
Why neglected tropical diseases are back on the UK agenda
The timing matters because the wider funding climate has worsened. On World NTD Day, WHO warned that official development assistance for NTDs fell 41% between 2018 and 2023, a slide it said threatens to reverse hard-won gains. Against that backdrop, even a £3 million research package can carry outsized significance if it helps improve diagnostics, delivery models and evidence for country-led programs.
Advocates at Westminster were also making a larger argument: NTD policy should no longer sit in a silo. Linking it to sexual and reproductive health, migrant health, primary care, mental health and routine community services makes the case less about stand-alone campaigns and more about whether health systems can reach people who are usually missed. That framing helps explain why the new funding was sold as operational research rather than a one-off political gesture.
Neglected tropical diseases and the UK’s longer arc
The Westminster gathering did not emerge in a vacuum. Britain was part of the 2012 London push to control or eliminate 10 NTDs by the end of the decade, a moment that helped make the diseases newly visible in global health diplomacy. In 2017, the government said it would more than double support and protect more than 200 million people, pairing mass treatment with research investment and setting a far bigger public benchmark for UK involvement.
Whether the latest pledge proves symbolic or catalytic will turn on follow-through: who gets the money, how fast it is disbursed and whether it opens the door to steadier UK backing. For now, Westminster has put neglected tropical diseases back in view and attached fresh money to the promise.
